The Federal Court of Australia in Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2019] FCA 28 has considered whether a generic manufacturer of a pharmaceutical product sold under a “skinny label” could be liable for indirect infringement of a patent. In this...

New Zealand has implemented a 12-month grace period for disclosures of an invention that occur on or after 30 December 2018. Australia has had a grace period since 2002. Perhaps surprisingly, given the moves to harmonise procedures in the two countries and the creation of...

Translate »